Tag Archives: Coverup

A Clinical Drug Trial Gone Wrong and the Unfinished Business of the Somalia Affair

As public awareness has grown in relation to the adverse health effects of the anti-malarial drug mefloquine in military veterans, much of the media attention has focused on a series of drug trials conducted by the Australian Defence Force in … Continue reading

Posted in Advocacy, Clinical Drug Trials | Tagged , , , , , , , , , , , | 1 Comment

PTSD as a “Diagnosis of Convenience”: Mefloquine, Tafenoquine and the Prevalence of Neuropsychiatric Disorders in ADF Veterans of East Timor and Bougainville

One of the problems that has perplexed many Australian government officials and veterans advocates in recent years is the disproportionately high number of Australian Defence Force (ADF) East Timor veterans who have been diagnosed with post-traumatic stress disorder (PTSD). PTSD is … Continue reading

Posted in Advocacy, Clinical Drug Trials, Research | Tagged , , , , , , , , , , , , , | 3 Comments

Scientific Misconduct in the Australian Army Malaria Institute’s Clinical Trials of Tafenoquine – Part 2

Part 1 of this series provided some background to the Australian Army Malaria Institute’s (AMI) tafenoquine trials in 1999-2002, including an outline of the preceding trials and more recent laboratory studies relating to the drug’s efficacy and toxicity. This post … Continue reading

Posted in Advocacy, Clinical Drug Trials, Research | Tagged , , , , , | Leave a comment

Loren Ries – Mefloquine, Tafenoquine and Lariam … Oh My

This is an excellent post by Loren Ries, shared with kind permission from her blog Loren Land. Loren is the wife of an Australian Army mefloquine and tafenoquine veteran who served in Timor Leste. This is her reaction the misinformation … Continue reading

Posted in Advocacy, Clinical Drug Trials, Our Stories | Tagged , , , , , , , , , | Leave a comment

Australian Army Malaria Institute Trial of Tafenoquine with 3 RAR Personnel in Timor Leste, February 2000

During the period 1999-2001 the Australian Army Malaria Institute (AMI) conducted a series of tafenoquine drug trials involving Australian Defence Force (ADF) personnel deployed on peacekeeping operations. The published trial reports include those involving members of the Peace Monitoring Group … Continue reading

Posted in Advocacy, Clinical Drug Trials, Research | Tagged , , , , , , , , | 4 Comments

Scientific Misconduct in the Australian Army Malaria Institute’s Clinical Trials of Tafenoquine – Part 1

The New Mefloquine? Mefloquine is now well known to be neurotoxic, one of several synthetic quinolines able to cause acute psychotic reactions and/or a chronic central nervous system (CNS) toxicity syndrome in a significant proportion of people given these drugs … Continue reading

Posted in Clinical Drug Trials, Media, Research | Tagged , , , , , , , , , | 2 Comments

CDC Staff Accused Injured U.S. Veteran of “Malingering” in Response to Official Drug Regulator Safety Warning on Mefloquine

FDA Black Box Warning In 2013 the U.S. Food and Drug Administration (FDA) issued a “black box” warning regarding the safety of the anti-malarial drug mefloquine. This is the most serious warning issued by the FDA, which in this case … Continue reading

Posted in Advocacy, Media, Research, Support | Tagged , , , , , , , , , , , , , | Leave a comment

Roche Shareholders: “Lariam Does Not Fit in with Roche’s Image”

Serious concerns over the safety of mefloquine (Lariam™) have not been limited to veterans, travellers or other consumers who have been adversely affected by the drug’s neurotoxic side effects. For many years, shareholders of the multinational Swiss manufacturer of the … Continue reading

Posted in Advocacy, Media, Research, Support | Tagged , , , , , , | Leave a comment